Software
By Pharma
For Pharma
A dynamic framework for evidence generation
planning and execution
DNA
Based on decades of Pharma and strategic consulting expertise
AESARA leadership team has held industry-based executive positions within HEOR/MA from small biotech to large pharmaceutical companies.
Every input is HEOR/MA focused Everything in one place
WHY?
What do they say about the need for Integrated Evidence Planning (IEP)?
“ At earlier stages of integration, companies still develop functional evidence generation plans bottom-up, and bring those plans together into an ‘integrated’ plan later. While this is a good starting basis it does not allow for the most efficient use of resources. In addition, we notice that involvement of countries (timing and number) varies across the companies and is less systematic in terms of the involvement of smaller yet progressive countries.”
PharmExec.com
Feb 04, 2020
OVERVIEW
ATLAS framework
Strategic roadmap to go from unmet need to patient access
Preparation
Anchor to strategic positioning
Direction
Develop value proposition
Execution
Drive value & access roadmap
Analysis
Identify gaps
Preparation
Direction
Execution
Analysis
Preparation
Anchor to strategic positioning
TARGET PRODUCT PROFILE
Competitive Landscape
Strategic Imperatives
Critical Success Factors
Market Access Goals
HIGHLIGHTS
Single source of truth for your value proposition and value evidence
Everything
in
ONE
place
Up to date product strategy slides on demandPowerPoint Presentation ready output
Management dashboard to view and monitor KPIsEnable leadership insights
Role-based accessControl based on roles and responsibilities
Data securityVetted and approved by multiple pharma companies
OUTCOMES
Alignment
Connectivity
Visibility